Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2005
08/31/2005CN1661071A Relativity between C2 gene of apolipoprotein and essential hypertension
08/31/2005CN1661070A Relativityl between converzyme gene of angiotensin I and essential hypertension
08/31/2005CN1661069A Relativity between gene of angiotensin I converting enzyme and essential hypertension
08/31/2005CN1661068A Relativity between gene SNP of insulin receptor and essential hypertension
08/31/2005CN1661067A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661066A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661065A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661064A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661063A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661062A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661061A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661060A Relativity between gene SNP of insulin receptor and essential hypertension
08/31/2005CN1661059A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661058A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661057A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661056A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661055A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661054A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661053A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661052A Relativity between gene of endothelin 1 and essential hypertension
08/31/2005CN1661051A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661050A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661049A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661048A Relativity between proto-oncogene of leukaemia in myeloblast class essential hypertension
08/31/2005CN1661047A Relativity between proto-oncogene of leukaemia in myeloblast class and essential hypertension
08/31/2005CN1661046A Relativity between synthetase of endothelium-nitrogen oxide and essential hypertension
08/31/2005CN1661045A Relativity between proto-oncogene of leukaemia in myeloblast class and essential hypertension
08/31/2005CN1661043A Biosensor prepared from embedding enzyme of sol-gel composite membrane of ion liquid
08/31/2005CN1661042A Method for screening out medication of anti tumours with HIF as target point and application
08/31/2005CN1661041A Method for preparing endotoxin indicator in use testing dry heat sterilization devices in tunnel type
08/31/2005CN1661040A Method for screening drug resistant reversion agent for multiple drugs of treating tumors mediated by protein group of anti transportation
08/31/2005CN1661039A Method for preparing chips of cell and equipment
08/31/2005CN1661014A Novel method to isolate mutants and to clone the complementing gene
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660900A CUDR as biomarker for cancer progression and therapeutic response
08/31/2005CN1660877A Nucleotide specific to O-antigen of 0177 type bacillus coli
08/31/2005CN1660876A Nucleotide specific to 0174 type O antigen of bacillus coli
08/31/2005CN1660875A Nucleotide specific to O-antigen of 025 type b acillus coli
08/31/2005CN1217194C Protein chip and its preparing process and application
08/31/2005CN1217192C Photoelectrochemical tag, method, instrument and kit for photoelectrochemical analysis
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1217189C Method for quantitating leukocyte count in whole blood sample
08/31/2005CN1217182C Fluorescence detecting system for quantitative gene magnification instrument
08/31/2005CN1217009C Process for producing hydrogel biochip by using epoxy-contained radial polyethylene glycol derivative
08/31/2005CN1217008C Reagent box, method software and composite medicine for predicting effect of ACEI hypotensors
08/31/2005CN1217007C Assay for measurement of DNA synthesis rates
08/31/2005CN1217006C Method for quantitative determination of biochemical substance by enzyme analysis via predicting background
08/31/2005CN1217005C New type fluid for sampling microorganism in air
08/31/2005CN1217004C Fast diagnosis reagent for genital tract chlamydia trachomatis
08/31/2005CN1217003C Micro array reaction apparatus and uses thereof
08/31/2005CN1216998C Technical scheme for increasing maricolous thermobacillus xylanase B gene expression level by large margin
08/31/2005CN1216995C DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses
08/31/2005CN1216990C Plant promoter and gene expression with the use of the same
08/31/2005CN1216902C Specific protein of SARS virus, clinical detection method and kit
08/31/2005CN1216894C Nucleic acid amplification using hairping dtructure to produce signal ad detecting method
08/31/2005CN1216640C Live vaccine for human immunodeficiency virus
08/31/2005CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease
08/30/2005US6936728 Production of hydroxylated fatty acids in genetically modified plants
08/30/2005US6936702 Charge-switch nucleotides
08/30/2005US6936695 Manufacture and expression of large structural genes
08/30/2005US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon
08/30/2005US6936693 Specific polypeptides, useful as nematocides
08/30/2005US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936687 Compositions for the detection of enzyme activity in biological samples and methods of use thereof
08/30/2005US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
08/30/2005US6936593 Method of down-regulating gene expression
08/30/2005US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET)
08/30/2005US6936461 Method for immobilizing multistranded nucleic acid molecules by modifying more than one strand thereof, and binding each strand to a solid support
08/30/2005US6936453 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
08/30/2005US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule
08/30/2005US6936451 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
08/30/2005US6936443 Detection and typing of human papillomavirus using PNA probes
08/30/2005US6936442 Amplification; genetic engineering
08/30/2005US6936435 Compositions and methods for regulating bacterial pathogenesis
08/30/2005US6936434 Sterilization using hydrogen peroxide vapors
08/30/2005US6936433 Methods and devices for characterizing duplex nucleic acid molecules
08/30/2005US6936430 detecting coagulation abnormalities in a plasma sample by determining a test rate of thrombin generation over a given time interval by reacting activator of thrombin with defibrinated normal plasma in presence of defibrinated test plasma sample
08/30/2005US6936424 Materials and methods for detection and treatment of breast cancer
08/30/2005US6936422 Staphylococcus culture; genetic engineering
08/30/2005US6936421 Structurally biased random peptide libraries based on different scaffolds
08/30/2005US6936420 Method of amplification of one or more DNA sequences in a DNA containing sample and methods of investigating such samples
08/30/2005US6936419 used for the detection of cytosine methylations in genomic DNA
08/30/2005US6936417 Gene expression in bladder tumors
08/30/2005US6936416 Expression monitoring for human cytomegalovirus (HCMV) infection
08/30/2005US6936415 Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more DNA's using primers having matched melting temperatures
08/30/2005US6936414 Nucleic acid isolation method and kit
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005US6936245 Mediators of signal transduction
08/30/2005US6935165 Microscale sensor element and related device and method of use
08/30/2005CA2294566C Ikk-.alpha. proteins, nucleic acids and methods
08/30/2005CA2212043C Method for assay of analyte by adjustment of chemiluminescence
08/26/2005CA2456595A1 Process for identifying eukariotic tumor cells or bacteria arboring a genomic alteration in at least one part of a gene encoding for a transcription factor
08/25/2005WO2005078453A2 Proteome epitope tags and methods of use thereof in protein modification analysis
08/25/2005WO2005078449A1 Method and kit for identifying the function of gene product and identifying binding substance
08/25/2005WO2005078440A2 Preparation of biologically derived fluids for biomarker determination by mass spectrometry
08/25/2005WO2005078427A1 Device for instantaneous and continuous measurement of substances in an aqueous phase
08/25/2005WO2005078424A1 Analyte sensor, and associated system and method employing a catalytic agent
08/25/2005WO2005078139A2 DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
08/25/2005WO2005078138A1 Target genes for inflammatory bowel disease
1 ... 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 ... 3003